|
WO9932211A1
|
|
Recovery of functional human leukocytes from recycled filters
|
|
US5676942A
|
|
Composition containing human alpha interferon species proteins and method for use thereof
|
|
CA2129533A1
|
|
Improved alpha interferon composition and method for its production from human peripheral blood leukocytes
|
|
US5516515A
|
|
Separation of alpha interferon receptor proteins and antibodies therefor
|
|
WO8903225A1
|
|
Purification of monomeric interferon
|
|
WO8900604A1
|
|
Method for improving translation efficiency
|
|
EP0294216A2
|
|
A functional assay for T-Lymphocytes
|
|
EP0284249A1
|
|
Lyophilized lymphokine composition
|
|
US4977087A
|
|
Method of regenerating plantlets from mesophyll protoplasts of phaseolus angularis
|
|
WO8805536A1
|
|
Multicolour western blot
|
|
IL84170D0
|
|
Method for detecting interferon
|
|
US4765903A
|
|
Purification of monomeric interferon
|
|
EP0240224A2
|
|
An alpha interferon analogue
|
|
US4744907A
|
|
Blood cell separation
|
|
IL77975A
|
|
Topical therapeutic composition containing oxidation inhibitor system
|
|
EP0154576A1
|
|
Hybrid nucleic acid sequences having tandemly arranged genes
|
|
US4710376A
|
|
Topical therapeutic composition containing oxidation inhibitor system
|
|
US4499014A
|
|
Method for purifying gamma-interferon
|
|
US4680175A
|
|
Interferon administration vehicles
|
|
US4591557A
|
|
Process and materials for producing soluble biological mediators from white blood cells
|
